P. Deschamps, E. Lara, W. Marande, P. Lopez-garcia, F. Ekelund et al., Phylogenomic analysis of kinetoplastids supports that trypanosomatids arose from within bodonids, Mol. Biol. Evol, vol.28, pp.53-58, 2011.

K. Stuart, R. Brun, S. Croft, A. Fairlamb, R. E. Gürtler et al., Kinetoplastids: related protozoan pathogens, different diseases, J. Clin. Invest, vol.118, pp.1301-1310, 2008.

D. H. Molyneux, L. Savioli, and D. Engels, Neglected tropical diseases: progress towards addressing the chronic pandemic, Lancet, vol.389, pp.312-325, 2017.

P. J. Hotez, D. H. Molyneux, A. Fenwick, J. Kumaresan, S. E. Sachs et al., Control of neglected tropical diseases, N. Engl. J. Med, vol.357, pp.1018-1027, 2007.

, Accessed, 2019.

P. and L. Pape, Development of new antileishmanial drugs e current knowledge and future prospects, J. Enzym. Inhib. Med. Chem, vol.23, pp.708-718, 2008.

, Accessed, 2019.

, WHO Interim Guidelines for the Treatment of Gambiense Human African Trypanosomiasis, WHO, 2019.

E. , Fexinidazole Deeks, First global approval, Drugs, vol.79, pp.215-220, 2019.

, Accessed, 2019.

, Accessed, 2019.

K. M. Bonney, D. J. Luthringer, S. A. Kim, N. J. Garg, and D. M. Engman, Pathology and pathogenesis of Chagas heart disease, Annu. Rev. Pathol, vol.14, pp.421-447, 2019.

N. Primas, C. Ducros, P. Vanelle, and P. Verhaeghe, The renewal of interest in nitroaromatic drugs: toward new anti-kinetoplastid agents, pp.250-280, 2019.

A. M. Thompson, P. D. O'connor, A. Blaser, V. Yardley, L. Maes et al., ]oxazoles for neglected tropical diseases: structureeactivity studies on a preclinical candidate for visceral leishmaniasis, J. Med. Chem, vol.59, pp.2530-2550, 2016.

A. M. Thompson, P. D. O'connor, A. J. Marshall, V. Yardley, L. Maes et al., ]oxazines: novel antitubercular agents lead to a new preclinical candidate for visceral leishmaniasis, J. Med. Chem, vol.7, pp.4212-4233, 2017.

A. Fairlamb, S. Patterson, S. Wylie, and K. Read, , 2017.

F. Mathias, M. D. Crozet, Y. Kabri, and P. Vanelle, Rapid synthesis of new 2-methyl-7-nitro-5-substituted-2,3-dihydroimidazo[5,1-b]oxazole as potential antibacterial drugs through one-pot cyclization and SuzukieMiyaura coupling, Synth. Commun, vol.48, pp.1213-1219, 2018.

F. Mathias, Y. Kabri, M. D. Crozet, and P. Vanelle, Efficient access to original 6-substituted 5-Nitro-2,3-dihydro-imidazo[2,1-b]oxazoles, Synthesis, vol.49, pp.2775-2785, 2017.

N. Shashiprabha, S. P. Nayak, K. S. Rao, K. Nagarajan, K. Shridhara et al., Nitroimidazooxazoles(#) part xxiv, search for antileishmanial agents: 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles as potential antileishmanial agents, Indian J. Pharmaceut. Sci, vol.76, pp.92-95, 2014.

K. C. Agrawal, K. B. Bears, R. K. Sehgal, J. N. Brown, P. E. Rist et al., Potential radiosensitizing agents. Dinitroimidazoles, J. Med. Chem, vol.22, pp.583-586, 1979.

R. K. Sehgal, M. W. Webb, and K. C. , Potential radiosensitizing agents. 2. Synthesis and biological activity of derivatives of dinitroimidazole with oxiranes, J. Med. Chem, vol.24, pp.601-604, 1981.

V. O. Iaroshenko, A. Gevorgyan, S. Mkrtchyan, K. Arakelyan, T. Grigoryan et al., Transition-metal-catalyzed arylation of nitroimidazoles and further transformations of manipulable nitro group, J. Org. Chem, vol.80, pp.2103-2119, 2015.

C. Rodriguez-antona, M. T. Donato, A. Boobis, R. J. Edwards, P. S. Watts et al., Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells, Xenobiotica, vol.32, pp.505-520, 2002.

D. Vita, F. Moraca, C. Zamperini, F. Pandolfi, R. D. Santo et al., In vitro screening of 2-(1H-imidazole-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51, Eur. J. Med. Chem, vol.113, pp.28-33, 2016.

F. Saccoliti, V. N. Madia, V. Tudino, A. Leo, L. Pescatori et al., Biological evaluation and structureactivity relationships of imidazole-based compounds as antiprotozoal agents, Eur. J. Med. Chem, vol.156, pp.53-60, 2018.

L. Friggeri, L. Scipione, R. Costi, M. Kaiser, F. Moraca et al., New promising compounds with in vitro nanomolar activity against Trypanosoma cruzi, ACS Med. Chem. Lett, vol.4, pp.538-541, 2013.
URL : https://hal.archives-ouvertes.fr/pasteur-01054197

G. Chauvi-ere, B. Bouteille, B. Enanga, C. De-albuquerque, S. L. Croft et al., Synthesis and biological activity of nitro heterocycles analogous to megazol, a trypanocidal lead #, J. Med. Chem, vol.46, pp.427-440, 2003.

M. V. Papadopoulou, B. B. Trunz, W. D. Bloomer, C. Mckenzie, S. R. Wilkinson et al., Novel 3-nitro-1H-1,2,4-triazole-Based aliphatic and aromatic amines as anti-chagasic agents, J. Med. Chem, vol.54, pp.8214-8223, 2011.

S. R. Pedada, V. S. Satam, P. J. Tambade, S. A. Kandadai, R. M. Hindupur et al., An improved kilogram-scale synthesis of 2-Bromo-4-nitro-1 H -imidazole: a key building block of nitroimidazole drugs, Org. Process Res. Dev, vol.17, pp.1149-1155, 2013.

T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, vol.65, pp.55-63, 1983.

J. Guillon, C. Boudot, A. Cohen, S. Savrimoutou, S. Rubio et al., Synthesis of 1H-3-{4-[(3-dimethylaminopropyl)aminomethyl] phenyl}-2-phenylindole and evaluation of its antiprotozoal activity, Molbank, p.1060, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02149772

C. Fersing, L. Basmaciyan, C. Boudot, J. Pedron, S. Hutter et al., Nongenotoxic 3-nitroimidazo[1,2-a]pyridines are NTR1 substrates that display potent in vitro antileishmanial activity, ACS Med. Chem. Lett, vol.10, pp.34-39, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02478935

C. Fersing, C. Boudot, J. Pedron, S. Hutter, N. Primas et al., Vanelle, 8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases, Eur. J. Med. Chem, vol.157, pp.115-126, 2018.

J. Guillon, A. Cohen, R. N. Das, C. Boudot, N. M. Gueddouda et al., Chem. Biol. Drug Des, vol.2, pp.974-995, 2018.

M. Recher, A. P. Barboza, Z. Li, M. Galizzi, M. Ferrer-casal et al., Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents, Eur. J. Med. Chem, vol.60, pp.431-440, 2013.

A. Jonet, J. Guillon, C. Mulli-e, A. Cohen, G. Bentzinger et al., Synthesis and antimalarial activity of new enantiopure aminoalcoholpyrrolo[1,2-a]quinoxalines, Med. Chem, vol.14, pp.293-303, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01789180